Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
DocMorris ( (CH:DOCM) ) has shared an announcement.
DocMorris has initiated the buyback offer period for its convertible bonds maturing in 2026, offering CHF 1,035.00 per bond, which is 103.50% of the nominal value, plus accrued interest. This move, announced after the buyback advertisement on October 22, 2025, is part of DocMorris’s strategic financial management, potentially impacting its market positioning and stakeholder interests, with the offer period ending on November 12, 2025.
The most recent analyst rating on (CH:DOCM) stock is a Hold with a CHF5.50 price target. To see the full list of analyst forecasts on DocMorris stock, see the CH:DOCM Stock Forecast page.
More about DocMorris
DocMorris AG is a prominent player in the online pharmacy, telemedicine, and marketplace sectors, with a strong presence in Germany and other European countries. The company operates a highly automated logistics center in the Netherlands and runs TeleClinic, Germany’s largest telemedicine platform. DocMorris also manages leading health and care product marketplaces in Southern Europe. With a vision to become a leading digital health companion, DocMorris serves over 10 million active customers and generated CHF 1,085 million in revenue in 2024.
Average Trading Volume: 398,576
Technical Sentiment Signal: Sell
Current Market Cap: CHF250.3M
Find detailed analytics on DOCM stock on TipRanks’ Stock Analysis page.